This post was originally published on this site
Chegg (NYSE:CHGG) 25% HIGHER; reported Q2 EPS of $0.28, in-line with the analyst estimate of $0.28. Revenue for the quarter came in at $182.85 million versus the consensus estimate of $176.5M. Total Net Revenues in the range of $151M to $153M, versus the consensus of $152.4M.
Alteryx (NYSE:AYX) 22% LOWER; reported Q2 EPS of ($0.37), $0.30 better than the analyst estimate of ($0.67). Revenue for the quarter came in at $188M versus the consensus estimate of $182.06M. Q2 revenue is expected to be in the range of $208M to $212M, representing year-over-year decline of (4)% to (2)%, versus the consensus of $233M. FY23 revenue is expected to be in the range of $930M to $940M, representing year-over-year growth of 9% to 10%, versus the consensus of $983.92M.
Maravai Lifesciences Holdings Inc (NASDAQ:MRVI) 11% LOWER; reported Q2 EPS of ($0.05), $0.06 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $68.91M versus the consensus estimate of $71.13M.
Beyond Meat (NASDAQ:BYND) 10% LOWER; reported Q2 EPS of ($0.83), $0.01 better than the analyst estimate of ($0.84). Revenue for the quarter came in at $102.1M versus the consensus estimate of $108.74M. Beyond Meat sees FY2023 revenue of $360-380M, versus the consensus of $388M.
Lucid Group Inc (NASDAQ:LCID) 3% HIGHER; reported Q2 EPS of ($0.40), $0.05 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $150.9M versus the consensus estimate of $191.41M.
